Taner Demirer

Summary

Affiliation: Ankara University
Country: Turkey

Publications

  1. ncbi Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation
    Taner Demirer
    Department of Bone Marrow Transplantation Unit, Ankara Numune Education and Research Hospital, Ankara, Turkey
    Br J Haematol 118:1104-11. 2002
  2. ncbi High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluation
    T Demirer
    Department of Hematology Oncology, Ankara University Medical School, Ankara, Turkey
    Bone Marrow Transplant 34:781-6. 2004
  3. ncbi Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF
    T Demirer
    Ankara Numune Education and Research Hospital, Bone Marrow Transplant Unit, Department of Hematology Oncology, Ankara University Medical School, Turkey
    Br J Haematol 116:468-74. 2002
  4. ncbi Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield
    Taner Demirer
    Ankara University Medical School, Department of Hematology Oncology and Bone Marrow Transplant, Ankara, Turkey
    Ther Apher 6:384-9. 2002
  5. ncbi High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults
    Paolo Pedrazzoli
    Divisione di Oncologia Medica Falck, Ospedale Niguarda Ca Granda, Milano, Italy, and Department of Hematology, Ankara University Medical School, Turkey
    Semin Hematol 44:286-95. 2007
  6. ncbi High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation
    T Demirer
    Ankara Numune Education and Research Hospital, Turkey
    Bone Marrow Transplant 31:755-61. 2003
  7. ncbi CD34+ cells in hematopoietic stem cell transplantation
    Taner Demirer
    Department of Hematology/Oncology and Bone Marrow Transplant Unit, Ankara University Medical School, Ibn-i Sina Hospital, Sihhiye, 06100 Ankara, Turkey
    Adv Exp Med Biol 534:107-18. 2003
  8. ncbi Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors
    Taner Demirer
    Department of Haematology Oncology, Ankara University Medical School, Turkey
    Nat Clin Pract Oncol 5:256-67. 2008
  9. ncbi An unusual presentation of plasma cell dyscrasias: cardiac tamponade due to myelomatous infiltration
    Mutlu Arat
    Department of Hematology, Ankara University Medical School, Ibni Sina Hospital, Turkey
    Leuk Lymphoma 43:145-8. 2002
  10. ncbi Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft versus host disease
    C Ustun
    Ankara University, School of Medicine, Department of Hematology Ibni Sina Hospital, Ankara, 06100, Turkey
    Pathol Oncol Res 5:229-32. 1999

Detail Information

Publications15

  1. ncbi Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation
    Taner Demirer
    Department of Bone Marrow Transplantation Unit, Ankara Numune Education and Research Hospital, Ankara, Turkey
    Br J Haematol 118:1104-11. 2002
    ..This study also showed that starting rhG-CSF administration on d 5 may be as effective as d 0 on the clinical outcome and may be an economical approach in routine clinical practice in this cost-conscious era...
  2. ncbi High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluation
    T Demirer
    Department of Hematology Oncology, Ankara University Medical School, Ankara, Turkey
    Bone Marrow Transplant 34:781-6. 2004
    ....
  3. ncbi Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF
    T Demirer
    Ankara Numune Education and Research Hospital, Bone Marrow Transplant Unit, Department of Hematology Oncology, Ankara University Medical School, Turkey
    Br J Haematol 116:468-74. 2002
    ..Therefore, in routine clinical practice, despite some advantage in the use of higher doses of rhG-CSF, lower doses may be used for PBSC collections following chemotherapy-based mobilization regimens in this cost-conscious era...
  4. ncbi Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield
    Taner Demirer
    Ankara University Medical School, Department of Hematology Oncology and Bone Marrow Transplant, Ankara, Turkey
    Ther Apher 6:384-9. 2002
    ..Using a value of 34/micro L preleukapheresis circulating CD 34+ cells as a guide for the timing of peripheral blood stem cells collections can be time saving and cost-effective...
  5. ncbi High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults
    Paolo Pedrazzoli
    Divisione di Oncologia Medica Falck, Ospedale Niguarda Ca Granda, Milano, Italy, and Department of Hematology, Ankara University Medical School, Turkey
    Semin Hematol 44:286-95. 2007
    ..In this article, we review and comment on the data from studies to date of HDC for solid tumors in adults...
  6. ncbi High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation
    T Demirer
    Ankara Numune Education and Research Hospital, Turkey
    Bone Marrow Transplant 31:755-61. 2003
    ..33. These preliminary data suggest that high-dose TMCb followed by autologous stem cell transplantation is an effective regimen for patients with advanced breast cancer and may be comparable to some previously used regimens...
  7. ncbi CD34+ cells in hematopoietic stem cell transplantation
    Taner Demirer
    Department of Hematology/Oncology and Bone Marrow Transplant Unit, Ankara University Medical School, Ibn-i Sina Hospital, Sihhiye, 06100 Ankara, Turkey
    Adv Exp Med Biol 534:107-18. 2003
  8. ncbi Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors
    Taner Demirer
    Department of Haematology Oncology, Ankara University Medical School, Turkey
    Nat Clin Pract Oncol 5:256-67. 2008
    ..Targeted therapies may complement the immune effect of allogeneic transplantation. We present updated results from the literature and data recently placed on file at the European Bone Marrow Transplantation Solid Tumors Working Party...
  9. ncbi An unusual presentation of plasma cell dyscrasias: cardiac tamponade due to myelomatous infiltration
    Mutlu Arat
    Department of Hematology, Ankara University Medical School, Ibni Sina Hospital, Turkey
    Leuk Lymphoma 43:145-8. 2002
    ..In conclusion, optimal treatment for malignant involvement of the pericardium by myeloma cells has not yet been established and is often fatal...
  10. ncbi Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft versus host disease
    C Ustun
    Ankara University, School of Medicine, Department of Hematology Ibni Sina Hospital, Ankara, 06100, Turkey
    Pathol Oncol Res 5:229-32. 1999
    ....
  11. ncbi Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case report
    C Ustun
    Department of Hematology Oncology, Ibn i Sina Hospital, Medical School, Ankara University, Turkey
    Ther Apher 3:275-7. 1999
    ..In conclusion, to treat and obtain a low titer of antibodies in a patient with AA following an ABO-incompatible alloPBSCT, higher doses of erythopoietin and corticosteroids associated with plasma exchange have to be used...
  12. ncbi A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters
    T Demirer
    Ankara Numune Hospital, Bone Marrow Transplant Unit, Ankara, Turkey
    Bone Marrow Transplant 29:893-7. 2002
    ..In fact, the use of the larger leukapheresis volume had the disadvantage of adding 60 min to the time the patient was on the machine...
  13. ncbi CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation
    T Demirer
    Department of Hematology and Bone Marrow Transplantation Unit, Ankara University Medical School, Ibn i Sina Hospital, Sihhiye, Ankara, Turkey
    J Clin Apher 16:67-73. 2001
    ..Based on this data we may conclude that flow cytometric measurement of CD41+ and CD42+ progenitor cells may provide an accurate indication of platelet reconstitutive capacity of the allogeneic PBSC transplant...
  14. ncbi Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation
    M Ozcan
    Ankara University School of Medicine, Department of Hematology, Ankara, Turkey
    Bone Marrow Transplant 27:499-505. 2001
    ..58 and 0.53, respectively). The administration of G-CSF after allogeneic PBSC transplantation provided faster neutrophil and platelet engraftment associated with less severe mucositis and less febrile episodes...
  15. ncbi Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation
    Simona Secondino
    Divisione Oncologica Falck, Ospedale Niguarda Ca Granda, Milan, Italy
    Haematologica 92:418-20. 2007
    ..Our study may suggest that an immune-mediated effect cannot be excluded in some STS...